Low Dose Naltrexone

Naltrexone was synthesized in 1963 as an orally active competitive opioid receptor antagonist. Naltrexone HCl was approved by FDA in 1984 for the treatment of opioid addiction.

Low-dose naltrexone (LDN) is a medication that has gained attention for its potential therapeutic benefits in various medical conditions. Naltrexone is an opioid receptor antagonist, which means it blocks the effects of opioids and can be used to treat opioid addiction.

Continue reading “Low Dose Naltrexone”